The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...
Computational point-of-care sensors can significantly improve access to diagnostics by enabling rapid patient testing outside ...
Huxley Medical, a commercial-stage medical technology company expanding access to sleep apnea testing across health systems, cardiology, and primary care, today introduced two additions to its SANSA® ...
Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus (HCV ...
Healthcare Asia Magazine on MSN
Global point-of-care testing market to hit $64.8b by 2031
This will be driven by increasing demand for quick testing. The global point-of-care testing (POCT) market is projected to ...
Point-of-care testing for group A beta-hemolytic Streptococcus (Strep A) significantly reduced antibiotic prescriptions in children and adults with signs of pharyngitis, even when used as the sole ...
Point of care testing in the emergency department: Finding comprehensive solutions that work for you
Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...
In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...
Integrating a rapid point-of-care polymerase chain reaction (PCR) testing for sexually transmitted infections (STIs) in the emergency department (ED) reduced the length of stay of patients by 76 ...
A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...
The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, registering a CAGR of 7.5% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results